Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marchesoni

Showing results (381-390 of 521) with videos related to

Pageof 53
Sort By:
Clinical and Experimental Rheumatology|February 25, 2011
The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanerceptEnnio Lubrano, Antonio Spadaro, Antonio Marchesoni, et al.
Gynecologic and Obstetric Investigation|April 19, 2002
Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsiaAngela V D'Elia, Lorenza Driul, Roberta Giacomello, et al.
Current Developments in Nutrition|November 21, 2022
Maternal Mediterranean Diet Adherence and Its Associations with Maternal Prenatal Stressors and Child GrowthSarah Gonzalez-Nahm, Joddy Marchesoni, Arnab Maity, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1986
Localized ovarian cancer: surgery plus chemotherapyM V Fiorentino, O Nicoletto, P de Besi, et al.
Clinical and Experimental Rheumatology|September 13, 2011
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for RheumatologyCarlo Salvarani, Nicolò Pipitone, Antonio Marchesoni, et al.
Reumatismo|January 10, 2009
Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)P Sarzi-Puttini, M Antivalle, A Marchesoni, et al.
Joint Bone Spine|June 5, 2013
Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scoresFabiola Atzeni, Sara Bongiovanni, Antonio Marchesoni, et al.
Epigenetics|December 15, 2023
Maternal adverse childhood experiences (ACEs) and offspring imprinted gene DMR methylation at birthAdriana C Vidal, David W Sosnowski, Joddy Marchesoni, et al.
The Journal of Rheumatology|June 3, 2011
Coronary flow reserve and asymmetric dimethylarginine levels: new measurements for identifying subclinical atherosclerosis in patients with psoriatic arthritisFabiola Atzeni, Piercarlo Sarzi-Puttini, Simona Sitia, et al.
Oncology Reports|July 16, 2004
BRCA2 germline mutations in primary cancer of the fallopian tubeSara Casarsa, Fabio Puglisi, Francesco Baudi, et al.
Pageof 53

Showing results (381-390 of 521) with videos related to

Sort By:
Pageof 53
Clinical and Experimental Rheumatology|February 25, 2011
The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanerceptEnnio Lubrano, Antonio Spadaro, Antonio Marchesoni, et al.
Gynecologic and Obstetric Investigation|April 19, 2002
Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsiaAngela V D'Elia, Lorenza Driul, Roberta Giacomello, et al.
Current Developments in Nutrition|November 21, 2022
Maternal Mediterranean Diet Adherence and Its Associations with Maternal Prenatal Stressors and Child GrowthSarah Gonzalez-Nahm, Joddy Marchesoni, Arnab Maity, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1986
Localized ovarian cancer: surgery plus chemotherapyM V Fiorentino, O Nicoletto, P de Besi, et al.
Clinical and Experimental Rheumatology|September 13, 2011
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for RheumatologyCarlo Salvarani, Nicolò Pipitone, Antonio Marchesoni, et al.
Reumatismo|January 10, 2009
Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)P Sarzi-Puttini, M Antivalle, A Marchesoni, et al.
Joint Bone Spine|June 5, 2013
Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scoresFabiola Atzeni, Sara Bongiovanni, Antonio Marchesoni, et al.
Epigenetics|December 15, 2023
Maternal adverse childhood experiences (ACEs) and offspring imprinted gene DMR methylation at birthAdriana C Vidal, David W Sosnowski, Joddy Marchesoni, et al.
The Journal of Rheumatology|June 3, 2011
Coronary flow reserve and asymmetric dimethylarginine levels: new measurements for identifying subclinical atherosclerosis in patients with psoriatic arthritisFabiola Atzeni, Piercarlo Sarzi-Puttini, Simona Sitia, et al.
Oncology Reports|July 16, 2004
BRCA2 germline mutations in primary cancer of the fallopian tubeSara Casarsa, Fabio Puglisi, Francesco Baudi, et al.
Pageof 53